Site icon AIT365

ScribeAmerica Continues to Evolve Speke AI Clinical Documentation Offering

ScribeAmerica 

ScribeAmerica has announced continued evolution and significant usage growth of their artificial intelligence scribe application Speke. Speke patient encounters more than doubled in the previous twelve months contributing to the approximate 30 million patient encounters ScribeAmerica services annually. As one of the first AI scribe solutions on the market, Speke by ScribeAmerica showcases how artificial intelligence can be deployed without compromising on the requirements of individual providers or the accuracy of healthcare data entered into the EHR.

“While artificial intelligence tools are becoming more common in clinical environments, we believe that providers shouldn’t have to sacrifice documentation quality or suffer using technology that doesn’t deliver on its promise,” says Tony Andrulonis, President at ScribeAmerica. “Speke is designed to fit seamlessly into a provider’s existing workflows and use the latest AI models to deliver documentation that is accurate, timely, and in line with the preferences of individual providers.”

Also Read: Leal Health Launches Next-Generation End-to-End Patient Support Platform Designed to Empower Cancer Patients to Navigate Their Treatment Journeys

Speke continues to be one of the most well-adopted AI scribe applications available on the market due to features such as:

“AI is evolving rapidly and we are committed to accelerated development of Speke to continue to meet the needs of individual physicians, independent medical groups, and large healthcare organizations alike,” says Vadim Khazan, Executive Vice President of Speke at ScribeAmerica. “ScribeAmerica continues to add top product talent and machine learning expertise from technology leaders like Amazon and Microsoft and we are excited about the big releases for Speke that will be available to providers very soon.”

Source: GlobeNewsWire

Exit mobile version